From: A novel genomic signature predicting FDG uptake in diverse metastatic tumors
Models | RMSE (t test adjusted p values) | R 2 (Wilcoxon test adjusted p values) |
---|---|---|
PLS vs PCR | 0.08936 | 0.3108 |
PLS vs RF | 5.3E−07 | 0.01667 |
PLS vs SVM | 0.0002238 | 0.000962 |
PCR vs RF | 2.087E−11 | 5.925E−5 |
PCR vs SVM | 2.198E−07 | 0.001221 |
RF vs SVM | 5.05E−06 | 0.2839 |